NL-OMON51205尚未招募2 期
Complement Inhibition: Attacking Overshooting inflammation @fter Subarachnoid Hemorrhage (CIAO@SAH trial) - CIAO@SAH
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 入组人数
- 128
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Confirmed diagnosis of aneurysmal subarachnoid hemorrhage on CT-scan
- •- Age >= 18 years on admission
- •- WFNS grade 1-5
排除标准
- •- Subarachnoid hemorrhage deemed most likely to *peri mesencephalic* origin
- •after consideration of history, clinical examination and radiological findings
- •(including angiographic imaging);
- •- Subarachnoid hemorrhage deemed most likely of post-traumatic origin after
- •consideration of history, clinical examination and radiological findings
- •(including angiographic imaging);
- •- Participation in another clinical therapeutic study;
- •- Patients with definite infaust prognosis on arrival and/or expected death
- •within 24 hours of admission;
- •- Patients with a known hereditary complement deficiency (including hereditary
- •angioedema);
- •- Patients with a history of sensibility to blood products or C1-inhibitor;
- •- Patients with a history of thrombosis (when known at time of inclusion);
- •- Pregnant woman.
研究者
相似试验
招募中
2 期
Complement Inhibition: Attacking the Overshooting Inflammation @fter Traumatic Brain Injury ( A phase II trial on the safety and efficacy of C1 esterase inhibitor Cinryze for the acute management of severe traumatic brain injury)NL-OMON52831eids Universitair Medisch Centrum106
尚未招募
2 期
CIAO@TBI2024-514488-24-02Leids Universitair Medisch Centrum (LUMC)106
进行中（未招募）
1 期
C1-inhibitor for the acute management of subarachnoid hemorrhageSubarachnoid hemorrhageEUCTR2020-005731-67-NLHaaglanden Medisch Centrum128
招募中
2 期
Randomized, controlled study of inflammation inhibition in the treatment of pneumonia by the SARS-Cov-2 virusCOMPVID STUDYPneumonia by the SARS-CoV-2 virusU.07.1RBR-88bjcvHospital Eduardo de Menezes
尚未招募
不适用
Identification of complement inhibitors and complement regulatory proteins in ABO-incompatible compare with HLA-incompatible kidney transplantatioABOi kidney transplantationHLAi kidney transplantationAccommodationABO incompatibility or ABO incompatible kidney transplantationComplement regulatory proteinsComplement inhibitorsHLA incompatibility or HLA incompatible kidney transplantationKidney transplantationTCTR20210904002/A30